Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 02/04/2026 | Q4 | $645.1M | -- | -- | $1.92 | -- |
| 11/04/2025 | Q3 | $577.8M | $561.9M | -$2.41 | -$1.80 | -$0.62 |
| 08/04/2025 | Q2 | $684.4M | $689.4M | -$3.62 | $0.85 | -$4.47 |
| 05/06/2025 | Q1 | $695M | $699.1M | $1.73 | $1.55 | $0.19 |
| 02/04/2025 | Q4 | $628.7M | $627.7M | -$12.00 | $2.07 | -$14.07 |
| 10/30/2024 | Q3 | $561.7M | $562.2M | -$2.05 | -$1.87 | -$0.18 |
| 07/31/2024 | Q2 | $658.2M | $666.3M | $0.75 | $0.76 | -$0.01 |
| 05/07/2024 | Q1 | $645.2M | $656.4M | -$0.07 | $0.45 | -$0.52 |
| 02/05/2024 | Q4 | $594.6M | $611M | -$0.13 | -$0.20 | $0.07 |
| 11/02/2023 | Q3 | -- | -- | -$1.44 | $0.15 | -$1.59 |
| 08/02/2023 | Q2 | -- | -- | $4.80 | $3.73 | $1.07 |
| 05/03/2023 | Q1 | -- | -- | $3.09 | $2.30 | $0.79 |
| 02/01/2023 | Q4 | -- | -- | $2.87 | $0.73 | $2.14 |
| 11/02/2022 | Q3 | -- | -- | -$2.58 | -$0.44 | -$2.14 |
| 08/03/2022 | Q2 | -- | -- | $0.24 | $1.00 | -$0.76 |
| 05/04/2022 | Q1 | -- | -- | -$0.44 | -$0.05 | -$0.39 |
| 02/02/2022 | Q4 | -- | -- | $0.59 | $1.17 | -$0.58 |
| 10/27/2021 | Q3 | -- | -- | $2.18 | $0.64 | $1.54 |
| 07/28/2021 | Q2 | -- | -- | $5.49 | $2.88 | $2.61 |
| 04/29/2021 | Q1 | -- | -- | $0.42 | -$2.81 | $3.23 |
| 02/03/2021 | Q4 | -- | -- | -$1.79 | -$2.34 | $0.55 |
| 10/28/2020 | Q3 | -- | -- | -$1.82 | -$5.18 | $3.36 |
| 07/29/2020 | Q2 | -- | -- | -$5.85 | -$5.50 | -$0.35 |
| 05/12/2020 | Q1 | -- | -- | -$2.08 | $1.02 | -$3.10 |
| 01/29/2020 | Q4 | -- | -- | $3.72 | $3.82 | -$0.10 |
| 10/24/2019 | Q3 | -- | -- | $2.70 | $2.21 | $0.49 |
| 07/24/2019 | Q2 | -- | -- | $4.50 | $4.70 | -$0.19 |
| 04/24/2019 | Q1 | -- | -- | $3.69 | $3.90 | -$0.20 |
| 01/30/2019 | Q4 | -- | -- | $2.56 | $2.47 | $0.09 |
| 10/24/2018 | Q3 | -- | -- | $0.94 | $0.96 | -$0.02 |
| 07/25/2018 | Q2 | -- | -- | $3.10 | $2.73 | $0.37 |
| 04/25/2018 | Q1 | -- | -- | $3.42 | $3.01 | $0.41 |
| 01/31/2018 | Q4 | -- | -- | $2.71 | $1.72 | $0.99 |
| 10/25/2017 | Q3 | -- | -- | $1.39 | $1.32 | $0.07 |
| 07/26/2017 | Q2 | -- | -- | $2.94 | $2.96 | -$0.02 |
| 04/25/2017 | Q1 | -- | -- | $2.50 | $2.56 | -$0.06 |
| 01/31/2017 | Q4 | -- | -- | $2.48 | $2.40 | $0.08 |
| 10/26/2016 | Q3 | -- | -- | $2.75 | $2.66 | $0.09 |
| 07/29/2016 | Q2 | -- | -- | $3.68 | $3.54 | $0.14 |
| 04/27/2016 | Q1 | -- | -- | $4.29 | $4.29 | -- |
| 01/27/2016 | Q4 | -- | -- | $3.38 | $3.17 | $0.21 |
Allegiant Travel Co. reported $561.9M worth of top line sales in its most recent quarter.
Allegiant Travel Co. announced earnings per share of -$2.41 which represents a miss of analyst forecast a -$1.80 per share.
Allegiant Travel Co. reported -$677K that represents -$0.04 per share over the last quarter.
Allegiant Travel Co.'s earnings are forecast to decrease from -$13.49 per share to $2.41 per share next year representing a decrease of -61.76%.
Allegiant Travel Co.'s next earnings date is February 4, 2026.
Signup to receive the latest stock alerts
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Market Cap: $4.6T
P/E Ratio: 64x
Market Cap: $4T
P/E Ratio: 37x
Market Cap: $3.8T
P/E Ratio: 39x
Hut 8 Corp. [HUT] is up 0.65% over the past day.
Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.
Structure Therapeutics, Inc. [GPCR] is down 2.36% over the past day.